Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Immunovia AB (publ)
AB
Active
Org 5567304299
Stockholm
Other human health activities n.e.c.
·
NACE 8699
Est. 2007 · 19 years old
1-4 employees
Monitor
Share
Sweden
/
Companies
/
Other human health activities n.e.c.
/
Immunovia AB (publ)
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
31M
23M
16M
8M
0M
2021: 10M
10M
2021
2022: 25M (+150% vs 2021)
25M
+150%
2022
2023: 13M (-48% vs 2022)
13M
-48%
2023
2024: 1M (-92% vs 2023)
1M
-92%
2024
2025: 1M (0% vs 2024)
1M
0%
2025
EBITDA
SEK millions
0M
-35M
-69M
-104M
-138M
2021: -111M
-111M
2021
2022: -89M (+20% vs 2021)
-89M
+20%
2022
2023: -80M (+10% vs 2022)
-80M
+10%
2023
2024: -58M (+28% vs 2023)
-58M
+28%
2024
2025: -24M (+59% vs 2024)
-24M
+59%
2025
Income statement
SEK thousands
Item
2025
2024
2023
2022
2021
Revenue
567
931
12 977
24 725
9 987
Staff expenses
—
—
—
—
—
EBITDA
−24 074
−58 113
−79 762
−89 203
−110 837
Depreciation & amort.
−387
−1 204
−134 186
−16 928
−11 685
EBIT
−24 461
−59 317
−213 948
−106 131
−122 522
Net financials
−91 995
−47 661
−93 871
−242 256
13 159
Profit before tax
−52 345
−106 978
−292 750
−331 147
−106 572
Tax
−0
−0
−0
−0
−0
Net profit
−52 345
−106 978
−292 750
−331 147
−106 572
Balance sheet
SEK thousands
Item
2025
2024
2023
2022
2021
Total assets
107 413
26 428
80 587
252 345
591 306
Equity
94 333
8 364
62 933
234 439
565 586
Long-term debt
0
0
0
0
0
Short-term debt
5 295
12 356
17 654
17 906
25 720
Total debt
5 295
12 356
17 654
17 906
25 720
Financial ratios
5-year trend
EBITDA margin
<−999 %
This company
15,8 %
Market median
This company
Market median
>999% below market
2021
2025
Equity ratio
87,8 %
This company
38,2 %
Market median
This company
Market median
130% above market
2021
2025
Return on equity
−55,5 %
This company
18,4 %
Market median
This company
Market median
402% below market
2021
2025
Net profit margin
<−999 %
This company
8,1 %
Market median
This company
Market median
>999% below market
2021
2025
Asset turnover
0,01×
This company
1,12×
Market median
This company
Market median
99% below market
2021
2025
Debt / equity
0,14×
This company
0,62×
Market median
This company
Market median
77% below market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
More on Immunovia AB (publ)
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
